Cas:204926-50-1 3(2H)-Furanone, 4-bromodihydro- manufacturer & supplier

Chemical Name:3(2H)-Furanone, 4-bromodihydro-

CAS.NO:204926-50-1

Synonyms:4-bromodihydrofuran-3(2H)-one;3(2H)-Furanone, 4-bromodihydro-;4-Bromo-dihydrofuran-3-one;4-Bromodihydro-3(2H)-furanone

Molecular Formula:C₄H₅BrO₂

Molecular Weight:164.985

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:213.6±40.0 °C at 760 mmHg

Density:1.8±0.1 g/cm3

Index of Refraction:1.529

PSA:26.30000

Exact Mass:163.947281

LogP:-0.53

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-bromodihydrofuran-3(2H)-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Bromodihydro-3(2H)-furanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Bromo-dihydrofuran-3-one Use and application,3(2H)-Furanone, 4-bromodihydro- technical grade,usp/ep/jp grade.

Related News: There were no cases of hospitalization or death among people who received the vaccine, the company reported. Side effects were mild — fatigue, headaches and muscle pain — and reactions tended to be less frequent than those triggered by some already authorized vaccines, the company said. 3(2H)-Furanone, 4-bromodihydro- manufacturer China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%. 3(2H)-Furanone, 4-bromodihydro- supplier Although bird flu poses more of a danger to poultry than humans �� it is not easily transmissible among people �� the World Health Organization has called on countries to be on guard because the virus can mutate into a transmissible form and has the potential to cause a pandemic. 3(2H)-Furanone, 4-bromodihydro- vendor There were no cases of hospitalization or death among people who received the vaccine, the company reported. Side effects were mild — fatigue, headaches and muscle pain — and reactions tended to be less frequent than those triggered by some already authorized vaccines, the company said. 3(2H)-Furanone, 4-bromodihydro- factory China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.